MH

Mahadevappa Hottigowder Sanjay

Active Director Director DIN 08640501
DIN 08640501 First appointment Dec 2019 Primary industry Electrnoics
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2019
Shareholding value β€’β€’β€’β€’ Premium profile

About Mahadevappa Hottigowder Sanjay

Data last updated:

Mahadevappa Hottigowder Sanjay is a Director at Lion Brothers Pharmaceuticals Private Limited (since 2019). The company operates in Electrnoics.

DIN 08640501
Primary Designation Director
Industry Electrnoics
First Appointment 17 Dec 2019
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 Dec 20192019Active

Board colleagues of Mahadevappa Hottigowder Sanjay

NameDINCompanyDesignation
Monirul Islam08640502Lion Brothers Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Lion Brothers Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Mahadevappa Hottigowder Sanjay

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mahadevappa Hottigowder Sanjay

Mahadevappa Hottigowder Sanjay currently holds 1 directorship: Lion Brothers Pharmaceuticals Private Limited (Director, since 17 Dec 2019).

Mahadevappa Hottigowder Sanjay was first appointed on 17 Dec 2019 as Director at Lion Brothers Pharmaceuticals Private Limited.

The current boards of Mahadevappa Hottigowder Sanjay's companies include Monirul Islam (Lion Brothers Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available